Nuo Therapeutics, Inc.
USD1.01
+0.00 (+0.00%)
CEO
David E. Jorden
IPO Date
2017-10-24
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$1.01
Prev. Close
$1.01
Day Low
$1.01
Day High
$1.01
52W Low
$0.84
52W High
$3.23
Market Cap
$0.05B
Volume
0.00M
| -27.4 |
| 31 Dec 2023 | FY | 79.3% | -521.2% | -305.2% | -168.9% | 0.25 | 2.32 | -7.3 |
| 31 Dec 2022 | FY | 82.9% | -2695.1% | -138.1% | -99.3% | 0.15 | 4.39 | -19.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 17.4% | -60.5% | 0.00 | 0.22 | -0.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 27.0% | -91.0% | 0.00 | 0.23 | -83.0 |
| 31 Dec 2019 | FY | 21.6% | -968.9% | 278.1% | -900.6% | -1.37 | 0.24 | -2.0 |
| 31 Dec 2018 | FY | 88.1% | -112.5% | 1880.6% | -158.1% | -3.77 | 0.82 | -0.6 |
| 31 Dec 2017 | FY | -51.3% | -2077.4% | -3102.0% | -1051.8% | 0.00 | 1.27 | -0.1 |
| 31 Dec 2016 | FY | 9.8% | 1019.6% | 174.0% | 154.9% | 0.00 | 2.77 | 0.1 |
| -40.3 |
| 30 Sept 2025 | Q3 | 60.6% | -52.1% | 128.2% | -27.9% | -0.27 | 1.16 | -45.1 |
| 30 Jun 2025 | Q2 | 77.2% | -92.8% | 78.8% | -47.8% | -0.16 | 0.85 | -27.0 |
| 31 Mar 2025 | Q1 | 75.0% | -154.0% | 350.2% | -65.1% | -0.70 | 0.47 | -18.8 |
| 31 Dec 2024 | Q4 | 78.1% | -125.8% | -96.7% | -41.8% | 0.32 | 1.45 | -33.0 |
| 30 Sept 2024 | Q3 | 72.9% | -155.9% | -64.9% | -33.6% | 0.20 | 1.88 | -11.5 |
| 30 Jun 2024 | Q2 | 82.1% | -148.1% | -90.2% | -38.0% | 0.32 | 1.70 | -7.9 |
| 31 Mar 2024 | Q1 | 78.4% | -302.2% | -212.6% | -57.0% | 0.63 | 1.29 | -15.3 |
| 31 Dec 2023 | Q4 | 79.0% | -331.5% | -62.9% | -34.8% | 0.25 | 2.32 | -9.0 |